Different Involvement of DNA Methylation and Histone Deacetylation in the Expression of Solute-Carrier Transporters in 4 Colon Cancer Cell Lines
Open Access
- 1 January 2012
- journal article
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 35 (3) , 301-307
Abstract
The purpose of this study on the involvement of epigenetic control of the expression of solute carrier (SLC) transporters by DNA methylation and histone deacetylation in 4 colon cancer cells is to find the epigenetic control mechanisms of drug transporters in colon cancers. Human colon cancer cell lines (HCT116, HT29, SW48, SW480) were treated with 5-aza-2′-deoxycytidine (DAC), as a DNA methyltransferase inhibitor, followed by trichostatin A (TSA), as a histone deacetylase inhibitor. The mRNA expression and DNA methylation of several SLC transporters were analyzed by real-time polymerase chain reaction (PCR) and methylation-specific PCR, respectively. Among 12 SLC transporters possessing cytosine-phosphate-guanine (CpG) islands, thiamine transporter 2 (THTR2) (SLC19A3) gene showed a correlation between its mRNA expression level and DNA methylation status. TSA treatment increased histone H3 acetylation of THTR2 promoter region in all 4 colon cancer cell lines examined. HCT116 and SW48 cells showed a lack of THTR2 mRNA expression and methylation of its promoter, and DAC treatment induced its re-expression. In addition, the co-treatment with DAC and TSA increased THTR2 mRNA expression more markedly than DAC treatment in HCT116 and SW48 cells. In HT29 and SW480 cells that showed little methylation of THTR2 promoter, TSA treatment induced THTR2 mRNA expression markedly, but DAC treatment did not. In the 4 colon cancer cells examined, THTR2 mRNA expression is down-regulated by DNA methylation and/or histone deacetylation.Keywords
This publication has 37 references indexed in Scilit:
- Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cellsEpigenetics, 2008
- The CpG Island Methylator Phenotype and Chromosomal Instability Are Inversely Correlated in Sporadic Colorectal CancerGastroenterology, 2007
- Classification of colorectal cancer based on correlation of clinical, morphological and molecular featuresHistopathology, 2006
- ABCG2 expression, function, and promoter methylation in human multiple myelomaBlood, 2006
- Aberrant Promoter Methylation of the ABCG2 Gene in Renal CarcinomaMolecular and Cellular Biology, 2006
- Epigenetic events in the colorectum and in colon cancerBiochemical Society Transactions, 2005
- MDR1, Chemotherapy and chromatin remodelingCancer Biology & Therapy, 2004
- The Role of ABC Transporters in Drug Resistance, Metabolism and ToxicityCurrent Drug Delivery, 2004
- Worms gang up on bacteriaNature Reviews Genetics, 2002
- CpG island methylator phenotype in colorectal cancerProceedings of the National Academy of Sciences, 1999